Skip to content
Screener

Globus Medical GMED Q3 2025 earnings

Reported November 6, 2025 · After market close

Revenue$769.0MBeat by $34.4M
EPS$1.18Beat by $0.40
Revenue estimate$734.7M
EPS estimate$0.78

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$792.2M
EPS estimate$1.20

Financials

Q3 2025

Income statement

See full
Revenue$769.0M+22.9%
Gross profit$516.5M+45.4%
Operating income$137.4M+186%
Net income$119.0M+130%
EPS (diluted)$0.88+132%

Balance sheet

See full
Cash & equivalents$371.8M-40.3%
Total debt$120.5M+20.2%
Total equity$4.4B+8.1%
Total assets$5.1B+0.2%

Cash flow

See full
Operating cash flow$249.7M+22.6%
CapEx$35.8M-14.6%
Free cash flow$213.9M+32.3%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$7.73B-20.2%
Enterprise value$7.48B-18.3%
P/E18.3×-87.6×
P/S2.8×-1.1×

Profitability

See full
Gross margin65.3%+7.2pp
Operating margin13.4%+8.7pp
Net margin15.3%+11.6pp
FCF margin20.9%+9.1pp

Returns & leverage

See full
Return on equity10%+7.8pp
Debt / equity0×0.0×
Current ratio4.1×+1.6×

FAQ

When did Globus Medical report Q3 2025 earnings?
Globus Medical (GMED) reported Q3 2025 earnings on November 6, 2025 after market close.
What were Globus Medical's Q3 2025 revenue and EPS?
Globus Medical reported revenue of $769.0M and eps of $1.18 for Q3 2025.
Did Globus Medical beat estimates in Q3 2025?
Revenue beat the consensus estimate of $734.7M by $34.4M. EPS beat the consensus estimate of $0.78 by $0.40.
How did Globus Medical's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 22.9% from $625.7M a year earlier and eps grew 42.2% from $0.83.
Where can I find Globus Medical's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001237831-25-000029) and the 10-Q periodic report (0001237831-25-000031) directly on SEC EDGAR. The filing index links above go to sec.gov.